Literature DB >> 20608227

Ataxia-telangiectasia mutated kinase (ATM) as a central regulator of radiation-induced DNA damage response.

Ales Tichý1, Jirina Vávrová, Jaroslav Pejchal, Martina Rezácová.   

Abstract

Ataxia-telangiectasia mutated kinase (ATM) is a DNA damage-inducible protein kinase, which phosphorylates plethora of substrates participating in DNA damage response. ATM significance for the cell faith is undeniable, since it regulates DNA repair, cell-cycle progress, and apoptosis. Here we describe its main signalling targets and discuss its importance in DNA repair as well as novel findings linked to this key regulatory enzyme in the terms of ionizing radiation-induced DNA damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20608227     DOI: 10.14712/18059694.2016.57

Source DB:  PubMed          Journal:  Acta Medica (Hradec Kralove)        ISSN: 1211-4286


  16 in total

Review 1.  Autophagy and genomic integrity.

Authors:  A T Vessoni; E C Filippi-Chiela; C Fm Menck; G Lenz
Journal:  Cell Death Differ       Date:  2013-08-09       Impact factor: 15.828

2.  Silibinin Preferentially Radiosensitizes Prostate Cancer by Inhibiting DNA Repair Signaling.

Authors:  Dhanya K Nambiar; Paulraj Rajamani; Gagan Deep; Anil K Jain; Rajesh Agarwal; Rana P Singh
Journal:  Mol Cancer Ther       Date:  2015-10-29       Impact factor: 6.261

Review 3.  Molecular Signaling in Response to Charged Particle Exposures and its Importance in Particle Therapy.

Authors:  Christine E Hellweg; Arif Ali Chishti; Sebastian Diegeler; Luis F Spitta; Bernd Henschenmacher; Christa Baumstark-Khan
Journal:  Int J Part Ther       Date:  2018-09-21

4.  Human T-lymphotropic virus type 1 p30 interacts with REGgamma and modulates ATM (ataxia telangiectasia mutated) to promote cell survival.

Authors:  Rajaneesh Anupam; Antara Datta; Matthew Kesic; Kari Green-Church; Nikolozi Shkriabai; Mamuka Kvaratskhelia; Michael D Lairmore
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

5.  Association between polymorphisms in TP53 and MDM2 genes and susceptibility to prostate cancer.

Authors:  Mohammad Hashemi; Shadi Amininia; Mahboubeh Ebrahimi; Nasser Simforoosh; Abbas Basiri; Seyed Amir Mohsen Ziaee; Behzad Narouie; Mehdi Sotoudeh; Mohammad Javad Mollakouchekian; Esmaeil Rezghi Maleki; Hamideh Hanafi-Bojd; Maryam Rezaei; Gholamreza Bahari; Mohsen Taheri; Saeid Ghavami
Journal:  Oncol Lett       Date:  2017-02-14       Impact factor: 2.967

6.  BMS-345541 sensitizes MCF-7 breast cancer cells to ionizing radiation by selective inhibition of homologous recombinational repair of DNA double-strand breaks.

Authors:  Lixian Wu; Lijian Shao; Manna Li; Junying Zheng; Junru Wang; Wei Feng; Jianhui Chang; Yan Wang; Martin Hauer-Jensen; Daohong Zhou
Journal:  Radiat Res       Date:  2012-12-21       Impact factor: 2.841

7.  Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441.

Authors:  Ales Tichy; Kamila Durisova; Barbora Salovska; Jaroslav Pejchal; Lenka Zarybnicka; Jirina Vavrova; Natalie A Dye; Zuzana Sinkorova
Journal:  Radiat Environ Biophys       Date:  2013-10-08       Impact factor: 1.925

8.  Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.

Authors:  Zi-Zhen Zhang; Yuan Jie Charles Liu; Xiao-Lu Yin; Ping Zhan; Yi Gu; Xing-Zhi Ni
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

9.  Functional proteomics analysis to study ATM dependent signaling in response to ionizing radiation.

Authors:  Amrita K Cheema; Rency S Varghese; Olga Timofeeva; Lihua Zhang; Alexander Kirilyuk; Fereshteh Zandkarimi; Prabhjit Kaur; Habtom W Ressom; Mira Jung; Anatoly Dritschilo
Journal:  Radiat Res       Date:  2013-05-03       Impact factor: 2.841

10.  Sodium glycididazole enhances the radiosensitivity of laryngeal cancer cells through downregulation of ATM signaling pathway.

Authors:  Yue-Can Zeng; Rui Xing; Jing Zeng; Ming Xue; Feng Chi; Yan Xin; Guo-Liang Fan; Hong-Mei Wang; Qiong-Yu Duan; Yu-Nan Sun; Nan Niu; Rong Wu
Journal:  Tumour Biol       Date:  2015-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.